MARK SCHOENEBAUM
Related Articles
Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
3 days ago
Lilly Stops Trial of Lymphoma Drug Due to Ineffectiveness
9 days ago
Gilead Misses Analysts’ Estimates on Sales of HIV Drugs
1 months ago
Gilead’s Hepatitis C Treatment Clears Virus in Eight Weeks
1 months ago
Actavis Seen Selling for Higher Valuation: Real M&A
1 months ago
Merck Cuts Profit Forecast as Buyback Boosted $15 Billion
1 months ago
Pfizer Lowers 2013 Forecast After Sales Miss Estimates
1 months ago
Biogen MS Pill’s Early Sales May Help It Beat Estimates
1 months ago
Pfizer’s Arthritis Drug Rejected by European Regulators
1 months ago
Biogen Raises 2013 Forecast After First-Quarter Profit Surges
1 months ago
Show More News
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=507494498&utmp=%2Ftopics%2Fmark-schoenebaum%2F%3FBB_NAVI_DISABLE%3DMARKETS_%2Fslideshow%2F%3Fcategory%3D%2Fnews%2Fenvironment%2Ftopic&utmhn=10.248.179.14&utmac=UA-11413116-12&utmhid=985763045&utme=8(1!BB_NAVI_DISABLE)9(1!MARKETS_%2Fslideshow%2F%3Fcategory%3D%2Fnews%2Fenvironment%2Ftopic)11(1!1))